A Christopher (Chris) Meredith Sells 50,510 Shares of Advanced Medical Solutions Group (LON:AMS) Stock

Key Points

• Chris Meredith, an insider at Advanced Medical Solutions Group, sold 50,510 shares at an average price of GBX 218, totaling almost £110,112.
• The stock experienced a slight decline, trading at GBX 211.50 with a recent trading volume significantly higher than its average.
• Equities analysts maintain a buy rating for AMS, with a consensus price target averaging GBX 273.67.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) insider A Christopher (Chris) Meredith sold 50,510 shares of the company's stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of GBX 218, for a total transaction of £110,111.80.

Advanced Medical Solutions Group Price Performance

LON:AMS traded down GBX 11.50 during mid-day trading on Thursday, hitting GBX 211.50. The company's stock had a trading volume of 1,392,048 shares, compared to its average volume of 810,282. The stock has a fifty day moving average of GBX 206.20 and a 200-day moving average of GBX 203.34. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The company has a market capitalization of £457.12 million, a price-to-earnings ratio of 6,507.69, a P/E/G ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group plc has a fifty-two week low of GBX 168.40 and a fifty-two week high of GBX 242.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last released its earnings results on Wednesday, September 17th. The company reported GBX 5.77 earnings per share for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. As a group, equities analysts forecast that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on AMS shares. Peel Hunt restated a "buy" rating and set a GBX 246 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 275 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, July 16th. Finally, Berenberg Bank reiterated a "buy" rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of GBX 273.67.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.